Lynx1 Capital Management’s TScan Therapeutics TCRX Stock Holding History

Lynx1 Capital Management’s Portfolio TCRX Stock Details TCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$11.4M	Buy
2025 Q1	$7.39M	Hold
2024 Q4	$16.3M	Buy
2024 Q3	$26M	Hold
2024 Q2	$30.6M	Hold
2024 Q1	$41.5M	Hold
2023 Q4	$30.5M	Hold
2023 Q3	$13.4M	Hold
2023 Q2	$13.1M	Buy